Recruiting Lupus Studies in Covina
A 2-stage, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
This study aims to evaluate the efficacy and safety of subcutaneous (SC) anifrolumab versus placebo in adult participants with cutaneous lupus erythematosus (CLE)....
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
This is a prospective, open-label, single arm 3-year clinical study to describe the short-term and long-term efficacy and safety of belimumab in participants with autoantibody positive early SLE with ...
About Lupus Clinical Trials in Covina
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, brain, and other organs. It is more common in women and often involves periods of flares and remission. Treatment includes antimalarials, immunosuppressants, and biologics.
There are currently 2 lupus clinical trials recruiting participants in Covina, CA. These studies are seeking a combined 810 participants. Research is being sponsored by AstraZeneca, GlaxoSmithKline. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lupus Clinical Trials in Covina — FAQ
Are there lupus clinical trials in Covina?
Yes, there are 2 lupus clinical trials currently recruiting in Covina, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Covina?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Covina research site will contact you about next steps.
Are clinical trials in Covina free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Covina studies also compensate for your time and travel.
What lupus treatments are being tested?
The 2 active trials in Covina are testing new therapies including novel drugs, biologics, and treatment approaches for lupus.
Data updated March 2, 2026 from ClinicalTrials.gov